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1052Objective: Limited data exist on patients with cardiac cachexia or morbid obesity presenting for valvular heart
surgery. The objective of this study was to investigate the relationship between body mass index and morbidity
and mortality after valvular surgery.
Methods:A retrospective review of 4247 patients undergoing valvular surgery from 1996 to 2008 at Emory Uni-
versity Healthcare Hospitals was performed. Patients were divided into 3 groups: body mass index 24 or less
(group 1, n ¼ 1527), body mass index 25 to 35 (group 2, n ¼ 2284), and body mass index 36 or more (group
3, n¼ 436). Data were analyzed using multivariable regression analysis, adjusted for 10 preoperative covariates.
A smooth kernel regression curve was generated using body mass index and in-hospital mortality as variables.
Long-term survival comparisons were made using adjusted Cox proportional hazards regression models and Ka-
plan–Meier product-limit estimates. Kaplan–Meier curves were generated that provide survival estimates for
long-term mortality using the Social Security Death Index.
Results: Patients in group 3 were significantly younger (group 1, 61.7 16.1 years; group 2, 61.9 13.6; group
3, 57.5 13.0; P<.001) and more likely to be female (group 1, 778/1527 [51.0%]; group 2, 912/2284 [39.9%];
group 3, 240/436 [55.0%]; P<.001). Mean ejection fractions were similar among groups (P ¼ .51). Patients in
group 2 had significantly shorter postoperative length of stay (group 1, 9.6 10.3 days; group 2, 8.7 8.2 days;
group 3, 10.8  11.0 days; P<.001). In-hospital mortality for the entire cohort was 5.8% (245/4247), and by
group was 111 of 1527 (7.3%) in group 1, 110 of 2284 (4.8%) in group 2, and 24 of 436 (5.5%) in group
3 (P ¼ .006). Actual survival at 1, 3, 5, and 10 years was significantly lower in group 1 (P<.001). A lower
body mass index was a significant independent predictor for both in-hospital and long-term mortality.
Conclusions: Patients with body mass index 24 or less are at significantly increased risk of in-hospital and long-
termmortality after cardiac valvular surgery. This high-risk patient population warrants careful risk stratification
and options for less-invasive valve therapies. (J Thorac Cardiovasc Surg 2011;142:1052-61)It has been well defined that obesity has a major influence
on the development of cardiovascular disease, leading
to worsening physical function and quality of life.1,2 The
alterations to the vascular endothelium as a consequence
of obesity include promotion of atherosclerosis, alteration
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The Journal of Thoracic and Cardiovascular Suradverse inflammatory milieu, and predisposition to
proteinuria and renal dysfunction.3 In light of the changes
to the vascular endothelium and the prevalence of obesity-
related coronary artery disease in the United States, the
majority of the literature regarding outcomes of obese
patients has concentrated on those undergoing coronary
artery bypass grafting (CABG) or mixed cardiac surgical
populations.4-13
Correspondingly, patients presenting with malnutrition
represent another high-risk group presenting with cardio-
vascular disease. In contrast with obesity, malnutrition is
an often overlooked preoperative comorbid condition in pa-
tients undergoing cardiac surgery.14 Although some have
noted that malnutrition increases short-term morbidity and
mortality after cardiac operations,15-17 others have shown
more favorable in-hospital outcomes.5 Studies evaluating
malnutrition have concentrated on patients undergoing
CABG.
The current study investigated the relationship between
body mass index (BMI) and morbidity and mortality in
4247 patients undergoing cardiac valvular surgery. Specifi-
cally, we evaluated unadjusted in-hospital morbidity andgery c November 2011
Abbreviations and Acronyms
AVR ¼ aortic valve replacement
BMI ¼ body mass index
CABG ¼ coronary artery bypass grafting
CI ¼ confidence interval
NYHA ¼ New York Heart Association
STS ¼ Society of Thoracic Surgeons
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Dmortality and long-term all-cause survival within different
quartiles of BMI values.MATERIALS AND METHODS
This study sought to characterize the relationship between BMI and
clinical outcomes after valve surgery. For descriptive purposes, patients
were classified into 3 groups according to their BMI classification by
O’Brien and colleagues:18 (1) 24 or less, (2) 25 to 35, and (3) 36 or
more. Patients were identified by querying the institutional Society of Tho-
racic Surgeons (STS) Adult Cardiac Database for consecutive patients who
underwent valve surgery at Emory Healthcare Hospitals between January
1, 1996, and June 30, 2008. Patients with concomitant CABG were in-
cluded, and patients undergoing emergency operation or operation under
salvage conditions were excluded.
During this period, 4649 consecutive patients underwent valve surgery.
Of these, 4247 patients (91.4%) had the available data to calculate BMI.
Thus, 402 patients were excluded because their BMI control was missing.
Extracted records included demographic data, preexisting comorbidities,
and clinical outcomes. The study was approved by the Emory University
Institutional Review Board in compliance with Health Insurance Portabil-
ity and Accountability Act regulations and the Declaration of Helsinki. The
institutional review board waived individual patient consent secondary to
the retrospective nature of the study.
Interventions, Surgeons, and Surgical Technique
Each patient underwent a single surgical session performed at the dis-
cretion of any of 19 faculty surgeons. Cardiac catheterization was per-
formed in all patients aged more than 40 years or in younger patients
with risk factors for coronary artery disease. Standard cardiopulmonary
bypass techniques for valve operations were used in all patients. Surgical
approach, valve prosthesis or repair techniques, and conduct of cardio-
pulmonary bypass and myocardial protection were left to the discretion
of the attending cardiac surgeon. Typically, conventional cardiopulmo-
nary bypass was performed using roller head pumps, membrane oxygen-
ators, cardiotomy suction, arterial filters, cold antegrade and retrograde
blood cardioplegia, and moderate systemic hypothermia (32C–34C).
The operative field was routinely flooded with carbon dioxide, and
de-airing maneuvers were performed in all cases before releasing the
crossclamp.
Long-Term Follow-up
The Social Security Death Index is a publicly available national data-
base of death records extracted from the US Social Security Administra-
tion’s Death Master File Extract. Patients with a Social Security Number
who have died since 1963 and whose death has been reported to the Social
Security Administration will be listed in the Social Security Death Index.
For each patient who died before the cutoff date of June 30, 2008, a mortal-
ity date was provided, allowing Kaplan–Meier long-term survival curves.
Cause of death is not available; thus, this study describes all-cause long-
term mortality.The Journal of Thoracic and CarVariables of Interest
Before analysis, 22 preoperative risk factors for the outcomes of interest
were identified and harvested from the STS database (Table 1). Standard
STS definitions for each risk factor and outcome were used. Race was di-
chotomized as Caucasian or non-Caucasian. Chronic lung disease was or-
dinally measured in some later years and dichotomously measured in
earlier years; in this study it was dichotomized. New York Heart Associa-
tion (NYHA) heart failure classification was dichotomized as class III/IVor
I/II. The primary outcomes examined in this study were in-hospital mortal-
ity and long-term survival; secondary end points included permanent stroke
(cerebrovascular accident), myocardial infarction, the composite end point
for any of these major adverse cardiac, and cerebrovascular events and op-
erative reintervention.
The institutional medical records STS database was populated by
trained personnel devoted exclusively to data management; thus, missing
data were scarce. Data were 100% complete for each major postoperative
hospital outcome. Data were missing for the following preoperative char-
acteristics: NYHA classification III/IV (n ¼ 1376, 32.4%), ejection
fraction (n¼ 771, 18.2%), last creatinine level (n¼ 735, 17.3%), and Cau-
casian race (n ¼ 336, 7.9%).
Data Management and Statistical Analysis
All data for consecutive patients were entered into a computerized
surgical database, using the fields and definitions of the STS National
Adult Cardiac Database. Checks for data quality were used at the insti-
tutional level and before final entry into the STS national adult cardiac
database.
A multiple imputation algorithm was used to impute missing values so
that the whole sample could be analyzed. This was not done in an effort
to re-create the truth; rather, the goal of the imputation was to avoid se-
lection bias that can occur by deleting cases with missing variables of
interest.
To initially evaluate the relationship between BMI and in-hospital mor-
tality, kernel estimation smoothing was used. To this end, a plot was created
where the x-axis was BMI and the y-axis was observed in-hospital mortal-
ity. Because observed mortality is dichotomous, the points on the plot at
each BMI value are calculated by taking an average of the observed mor-
tality (so-called uniform kernel smoothing) for a ‘‘neighborhood’’ around
the BMI value. The neighborhood is the collection of points within a small
range around the BMI value; thus, the point on the plot is the average mor-
tality rate for that small region of BMI values. The width of the neighbor-
hood was set at 15%, meaning that each point plotted represents a moving
average of 30% of the data.
To statistically evaluate the effects of BMI on in-hospital mortality,
a multivariable logistic regression model was constructed. The model con-
tains 10 additional preoperative covariates to adjust for potential selection
bias: age, sex, dialysis, renal failure, heart failure, ejection fraction, pres-
ence of concomitant CABG, infectious endocarditis, previous stroke, and
chronic lung disease. According to the smoothed curve, it was determined
that BMI has a parabolic relationship with mortality; thus, BMI and BMI2
were entered as a quadratic chunk into the regression model and evaluated
as a chunk. Adjusted odds ratios associated with BMI and other covariates,
along with 95% confidence intervals (CIs), were computed.
Long-term survival comparisons were made using adjusted Cox propor-
tional hazards regression models and Kaplan–Meier product-limit esti-
mates (unadjusted). Kaplan–Meier curves were generated that provide
survival estimates at postoperative points in time. Differences between
BMI classifications were determined by log-rank tests. These estimates in-
clude operative deaths.
Adjusted long-term survival comparisons were made by using propor-
tional hazards regression to model the instantaneous hazard of death as
a function of BMI and BMI2, adjusted for age, sex, dialysis, renal failure,
heart failure, ejection fraction, presence of concomitant coronary artery by-
pass, infectious endocarditis, previous stroke, and chronic lung disease.diovascular Surgery c Volume 142, Number 5 1053
TABLE 1. Preoperative characteristics
Characteristic
BMI  24
(n ¼ 1527)
BMI 25–35
(n ¼ 2284)
BMI  36
(n ¼ 436) P value
Age (mean  SD) 61.7  16.1 61.9  13.6 57.5  13.0 <.001
Female gender 778 (50.9%) 912 (39.9%) 240 (55.0%) <.001
Caucasian* 1111 (78.3%) 1661 (79.2%) 281 (71.3%) .003
Status .046
Elective 1293 (84.7%) 1966 (86.1%) 356 (81.7%)
Urgent 234 (15.3%) 317 (13.9%) 80 (18.3%)
Ejection fraction (mean%  SD)* 53.0  13.5 52.6  13.4 53.3  12.8 .51
Hypertension 855 (56.0%) 1540 (67.0%) 349 (80.1%) <.001
NYHA class 3 and 4* 475 (46.5%) 715 (46.9%) 169 (52.3%) .16
Diabetes 186 (12.2%) 501 (21.9%) 164 (37.6%) <.001
COPD* 273 (17.9%) 335 (14.7%) 101 (23.2%) <.001
Previous myocardial infarction 236 (15.5%) 372 (16.3%) 78 (17.9%) .46
Previous CVA 152 (10.0%) 183 (8.0%) 34 (7.8%) .09
Previous valve surgery 108 (33.6%) 108 (26.5%) 10 (13.2%) <.001
Cerebrovascular disease 229 (15.0%) 322 (14.1%) 63 (14.5%) .74
Peripheral vascular disease 100 (6.6%) 147 (6.4%) 22 (5.1%) .50
Mean preoperative serum creatinine* 1.46  1.68 1.38  1.50 1.38  1.45 .30
Chronic renal insufficiency 178 (11.7%) 204 (8.9%) 48 (11.0%) .019
Preoperative dialysis 82 (5.4%) 80 (3.5%) 20 (4.6%) .019
Infectious endocarditis 167 (10.9%) 168 (7.4%) 31 (7.1%) <.001
Dyslipidemia 298 (19.5%) 619 (27.1%) 159 (36.5%) <.001
Current smoker 424 (27.8%) 664 (29.1%) 145 (33.3%) .08
Preoperative IABP 8 (0.5%) 10 (0.4%) 2 (0.5%) .93
Immunosuppressive therapy 85 (5.6%) 107 (4.7%) 29 (6.7%) .17
STS Predicted risk of mortality* 4.9  5.2 3.8  4.0 3.5  3.7 <.001
BMI,Bodymass index; SD, standard deviation;NYHA,NewYork Heart Association;COPD, chronic obstructive pulmonary disease;CVA, cerebral vascular accident; IABP, intra-
aortic balloon pump. *Contains some missing data.
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of the Schoenfeld residuals and ranked follow-up time. Hazard ratios were
generated for each model term, along with 95% CI.
Data were managed and analyzed using SAS Version 9.1 (SAS Institute
Inc, Cary, NC). Unadjusted comparisons were performed with chi-square
tests and 2-sample t tests for categoric and continuous predictors, respec-
tively. All statistical tests were 2-sided using an a ¼ 0.05 level of signifi-
cance. No adjustments for multiple tests were made.RESULTS
Preoperative and Operative Characteristics
A total of 4247 patients underwent valve surgery at a sin-
gle academic institution and comprise the study group. The
patients were divided into 3 groups: group 1 (BMI  24,
n ¼ 1527), group 2 (BMI, 25–35; n ¼ 2284), and group 3
(BMI  36, n ¼ 436). Preoperative characteristics are
shown in Table 1. Notably, patients in group 3 were youn-
ger, more likely to be female, andmore likely to have hyper-
tension, diabetes mellitus, chronic obstructive pulmonary
disease, and dyslipidemia. Patients in group 1 were more
likely to have had previous valve surgery, preoperative dial-
ysis, and infectious endocarditis. In all groups, approxi-
mately one half of patients were in NYHA class III or IV,
and the ejection fraction was 53%. The STS predicted
risk of mortality was significantly higher in those patients
with BMI 24 or less.1054 The Journal of Thoracic and Cardiovascular SurTable 2 describes operative procedures according to BMI
group. Both aortic crossclamp and cardiopulmonary bypass
times were significantly longer in group 3. The most com-
mon valve surgery was aortic valve replacement (AVR) in
all groups. Bioprosthetic valve implantation was similar
among groups at approximately 50%. CABG and place-
ment of an intraoperative intraaortic balloon pump were
more common in group 3.
In-Hospital Morbidity and Mortality
Unadjusted in-hospital outcomes are described in Table
3. Overall, in-hospital mortality occurred in 245 patients
(5.8%). Mediastinitis, new renal failure, prolonged ventila-
tion, and total initial intensive care unit length of stay were
more common in group 3. However, in-hospital mortality
was significantly greater in group 1. The observed to STS
predicted risk of mortality expected ratio was 1.48 in group
1, 1.17 in group 2, and 1.25 in group 3. After adjusting for
10 covariates using a multivariable logistic regression anal-
ysis (Table 4), BMI trended as an independent predictor for
in-hospital mortality (odds ratio, 0.89; 95% CI, 0.78–1.01;
P ¼ .07). However, the following variables emerged as
statistically significant predictors of in-hospital mortality:
renal insufficiency, advanced age, female gender, endocar-
ditis, and previous stroke.gery c November 2011
TABLE 2. Operative characteristics for each body mass index group
Operative data
BMI  24
(n ¼ 1527)
BMI 25–35
(n ¼ 2284)
BMI  36
(n ¼ 436) P value
BMI 22.1  2.14
Median: 22.5
28.9  2.7
Median: 28.4
39.6  4.4
Median: 38.3
<.001
Aortic crossclamp time (min) (mean  SD) 85.0  32.7
Median: 80.0
90.4  32.5
Median: 85
96.8  37.7
Median: 89
<.001
CPB time (min) (mean  SD) 123.3  46.5
Median: 114
127.5  42.6
Median: 120
135.0  51.0
Median: 123
<.001
Isolated primary AVR 614 (40.2%) 1144 (50.1%) 246 (56.4%) <.001
AVR valve size implanted 22.7  2.4
Median: 23
Mean: 23.3  2.5
Median: 23
Mean: 23.4  2.4
Median: 23
<.001
Isolated primary MV procedure 449 (29.4%) 573 (25.1%) 82 (18.8%) <.001
Double valve procedure 205 (13.4%) 205 (9.0%) 41 (9.4%) <.001
Other valve procedures 242 (15.9%) 212 (9.3%) 46 (10.6%) <.001
Concomitant CABG 443 (29.0%) 818 (35.8%) 142 (32.6%) <.001
Bioprosthetic valve 791 (51.8%) 1131 (49.5%) 216 (49.5%) .36
Intraoperative IABP insertion 60 (3.9%) 126 (5.5%) 33 (7.6%) .005
BMI, Body mass index; SD, standard deviation; CPB, cardiopulmonary bypass; AVR, aortic valve replacement; MV, mitral valve; CABG, coronary artery bypass grafting; IABP,
intra-aortic balloon pump.
Thourani et al Acquired Cardiovascular Disease
A
C
DTo evaluate the relationship between BMI and in-hospital
mortality, kernel estimation smoothing was used and is rep-
resented in Figures 1 to 5. An initial analysis of all patients
(Figure 1) reveals the lowest in-hospital mortality in thoseTABLE 3. Unadjusted short-term postoperative outcomes for each age gr
Outcomes
BMI  24
(n ¼ 1527)
Myocardial infarction 7 (0.5%)
Cerebral vascular accident 48 (3.1%)
Mediastinitis 7 (0.5%)
Septicemia 59 (3.9%)
Heart block requiring pacemaker 51 (3.3%)
Multisystem failure 35 (2.3%)
New renal failure 105 (6.9%)
New dialysis 34 (2.2%)
Reexploration bleeding 113 (7.4%)
Need for intraoperative
PRBC transfusion
398 (26.1%)
Mean PRBC unit transfused 0.83  1.75
Postoperative pneumonia 105 (6.9%)
Postoperative ventilator (h)
(mean  SD)
41  118
Median: 11
Prolonged ventilation 190 (12.4%)
Postoperative IABP insertion 14 (0.9%)
New-onset atrial fibrillation 359 (23.5%)
Gastrointestinal complication 78 (5.2%)
Total initial ICU LOS (h)
(mean  SD)
107  177
Median: 47.0
Postoperative LOS (d)
(mean  SD)
9.6  10.3
Median: 6
In-hospital mortality 111 (7.3%)
STS PROM* 4.9  5.2
O/E mortality 7.3/4.9 ¼ 1.5 (n ¼ 907) 4.5/
BMI, Body mass index; SD, standard deviation; PRBC, packed red blood cell; IABP, intra
Thoracic Surgeons; PROM, predicted risk of mortality; O/E, observed to expected. *Data
The Journal of Thoracic and Carpatients with a normal BMI. Furthermore, this bimodal
curve reveals the highest mortality in those with the lowest
BMI and increasing mortality in those with a BMI greater
than 32. Further analysis revealed a similar curve for thoseoup
BMI 25–35
(n ¼ 2284)
BMI  36
(n ¼ 436) P value
15 (0.7%) 2 (0.5%) .69
50 (2.2%) 14 (3.2%) .14
18 (0.8%) 13 (3.0%) <.001
60 (2.6%) 19 (4.4%) .042
80 (3.5%) 14 (3.2%) .94
34 (1.5%) 12 (2.8%) .08
129 (5.7%) 41 (9.4%) .01
53 (2.3%) 12 (2.8%) .81
117 (5.1%) 17 (3.9%) .003
542 (23.7%) 95 (21.8%) .11
0.74  1.67 0.75  1.82 .26
131 (5.7%) 31 (7.1%) .28
37  110
Median: 8
58  152
Median: 12.9
.004
289 (12.7%) 93 (21.3%) <.001
16 (0.7%) 3 (0.7) .74
568 (24.9%) 103 (23.6%) .60
92 (4.0%) 20 (4.6%) .25
99  174
Median: 45.2
129  206
Median: 51
.035
8.7  8.2
Median: 6
10.8  11.0
Median: 7
<.001
110 (4.8%) 24 (5.5%) .006
3.8  4.0 3.5  3.7 <.001
3.8 ¼ 1.17 (n ¼ 1467) 4.4/3.5 ¼ 1.25 (n ¼ 295)
-aortic balloon pump; ICU, intensive care unit; LOS, length of stay; STS, Society of
missing.
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TABLE 4. Estimates of preoperative predictors of in-hospital survival
from multivariable logistic regression analysis
Preoperative variables
Odds ratio
(95% CI) P value
Age 1.04 (1.03–1.06) <.00001
Chronic lung disease 1.13 (0.81–1.58) .48
CVA 1.45 (0.98–2.13) .06
EF 0.99 (0.98–1.00) .19
Infectious endocarditis 1.78 (1.11–2.85) .02
Female gender 1.79 (1.35–2.36) .00004
Heart failure 1.23 (0.92–1.65) .16
Renal failure 2.44 (1.61–3.70) .00002
Renal failure requiring dialysis 2.36 (1.35–4.10) .002
CAD requiring CABG 1.32 (0.99–1.76) .06
BMI 0.89 (0.78–1.01) .07
CVA, Cerebrovascular accident; EF, ejection fraction; CAD, coronary artery disease;
CABG, coronary artery bypass grafting; BMI, body mass index.
Acquired Cardiovascular Disease Thourani et alA
C
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isolated mitral valve procedures (Figure 3), multiple valve
procedures (Figure 4), or concomitant CABG (Figure 5),
there was a significant increased mortality in those with
a lower BMI.
Long-term Mortality
The median follow-up for all patients was 4.4 years. Sur-
vival estimates for each group are shown in Table 5 and in
the Kaplan–Meier curve in Figure 6. When all patients were
grouped according to BMI status, 10-year survival was sig-
nificantly reduced among patients with a BMI of 24 or less
compared with those with higher BMI status (group 1:
53.5% vs group 2: 63.4% vs group 3: 62.2%; P<.001).FIGURE 1. Smooth kernel estimation of in-hospital mortality
1056 The Journal of Thoracic and Cardiovascular SurAfter multivariable adjustment, BMI was associated with
reduced long-term survival (hazard ratio, 0.91; 95% CI,
0.86–0.97; P¼ .002). Other significant independent predic-
tors of long-term mortality are listed in Table 6 and include
renal failure, older age, female sex, heart failure, endocardi-
tis, stroke, and chronic lung disease.DISCUSSION
Although data on malnourished surgical patients have
existed for some time, the role of low BMI as a risk factor
for morbidity and mortality has been largely ignored, likely
because of the burgeoning epidemic of obesity in the United
States. This study serves to add to the growing body of lit-
erature detailing increased morbidity and mortality in pa-
tients with low BMI after cardiac surgery. No study to
date has examined the relationship between BMI and out-
comes in patients undergoing strictly cardiac valvular
procedures.
Similar to prior studies on this topic, the current study
showed that obese patients (BMI>35) had a higher incidence
of certain morbidities and resource use after valvular sur-
gery.19,20 They experienced longer cardiopulmonary bypass
times, longer aortic crossclamp times, and a higher rate of
intraoperative balloon counterpulsation. Accordingly, they
also experienced a greater degree of postoperative renal
failure, mediastinitis, and prolonged ventilation. Although
these patients had prolonged intensive care unit and
hospital stay leading to increased resource use, they did not
have greater in-hospital mortality (5.5%) when compared
with patients with normal BMI (4.8%) and patients withfor the BMI range of all patients. BMI, Body mass index.
gery c November 2011
FIGURE 2. Smooth kernel estimation of in-hospital mortality for the BMI range of patients undergoing isolated AVR. BMI, Body mass index.
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Dthe lowest BMI (7.3%). These data are consistent with other
researchers who have noted an ‘‘obesity paradox’’ in a mixed
cardiac surgical population showing decreased in-hospital
and long-term mortality when compared with normal-
weight patients.12 It is plausible that obese patients likely
self-select, and thosewho undergo surgery have greater func-
tional reserve than patients with low BMI. These similar
trends for the obese patients reveal a 10-year survival similarFIGURE 3. Smooth kernel estimation of in-hospital mortality for the BMI rang
index.
The Journal of Thoracic and Carto that of patients with normal BMI and significantly higher
survival than that of patients with the lowest BMI. Data exist
supporting the fact that overweight patients have lower mor-
tality after cardiovascular events associatedwith coronary ar-
tery disease and lower mortality from heart failure.3,21
Outcomes delineating the effects of malnutrition for
patients undergoing cardiac surgery have been sparingly
evaluated. Engelman and colleagues15 evaluated a mixede of patients undergoing isolated mitral valve procedures. BMI, Body mass
diovascular Surgery c Volume 142, Number 5 1057
FIGURE 4. Smooth kernel estimation of in-hospital mortality for the BMI range of patients undergoing multiple valve procedures. BMI,Body mass index.
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CABG and valvular surgery. In a study that included
more than 5000 patients (68% undergoing CABG), these
researchers found that BMI less than 20 was independently
associated with increased mortality, incidence of stroke, re-
nal failure, and reexploration for hemorrhage after cardio-
pulmonary bypass. Although no plausible explanations
were offered for the observed results in this study, the au-
thors concluded that low BMI should be included in risk
stratification models for cardiac surgery. In a populationFIGURE 5. Smooth kernel estimation of in-hospital mortality for the BMI ran
Body mass index.
1058 The Journal of Thoracic and Cardiovascular Surof more than 4000 patients undergoing isolated CABG in
the United Kingdom, Reeves and colleagues9 found an in-
creased incidence of in-hospital mortality, renal failure,
and prolonged ventilation in patients with BMI less than
20. Potapov and colleagues17 published results of approxi-
mately 23,000 patients who underwent isolated CABG or
CABG with valve surgery. The large number of patients
in this study allowed researchers to separate patients into
20 separate BMI groups. The results from this study con-
firmed prior data in that patients with low BMI were atge of patients undergoing valve procedures with concomitant CABG. BMI,
gery c November 2011
TABLE 5. Survival estimates for each age group
Age group 1-y survival 3-y survival 5-y survival 10-y survival P value
BMI  24 (n ¼ 1527) 84.9% 77.7% 70.9% 53.5% <.001
BMI 25–35 (n ¼ 2284) 89.2% 84.5% 78.3% 63.4%
BMI  36 (n ¼ 436) 88.1% 80.2% 73.3% 62.2%
BMI, Body mass index.
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Dincreased risk for 30-day mortality, renal failure, reintuba-
tion, and reexploration for hemorrhage.
In the current series, patients with low BMI had the high-
est in-hospital mortality when compared with patients with
normal and high BMI as indicated by the observed to ex-
pected ratios and smooth kernel curves (Figure 1). The bi-
modal curves associated with in-hospital mortality were
similar for those undergoing isolated AVR (Figure 2) and
all patients undergoing valve surgery (Figure 1). However,
the bimodal nature of the curves was not apparent in those
undergoing mitral valve procedures, multiple valve surger-
ies, or concomitant CABG (Figures 3–5), with an increased
in-hospital mortality highest among patients with a low
BMI and morbidly obese patients. Although epidemiologic
data suggest U- or J-shaped curves in relation to BMI and
mortality,2,22 the pathophysiologic perturbations of these
curves in patients undergoing valvular surgery deserve
further investigation.
It is plausible that patients who are underweight, when
compared with patients with higher BMI, may not have
the necessary metabolic reserve to overcome the further in-
creased catabolic stress resulting from a stressful opera-
tion.3 In addition, a low BMI has been associated with
increased hemodilution during cardiopulmonary bypass
and a greater postoperative coagulopathy, whereas obesityFIGURE 6. Kaplan–Meier survival estimates for patients with BMI 24
The Journal of Thoracic and Carhas been associated with a protective effect on postopera-
tive hemorrhage.4 Ranucci and colleagues23 have detailed
an increased risk of postoperative hemorrhage requiring re-
exploration in patients with a low BMI. Although we did
note an increased reexploration rate in group 1 in the current
study, there was no difference in red cell transfusion among
groups. The correlation of hypoalbuminemia as a surrogate
for overall nutrition and poor outcomes after cardiac sur-
gery remains divided.15,24,25
In addition to in-hospital morbidity andmortality, the cur-
rent study evaluated all-cause long-term mortality in the
low, normal, and high BMI groups. We have demonstrated
a significant decrease in long-term survival associated
with low BMI compared with the other BMI groups. Al-
though patients in the low BMI group had more comorbid-
ities and a greater preoperative predicted risk of mortality,
they had greater long-term mortality that was unpredicted
by a standard preoperative risk assessment tool. Prior studies
have shown BMI and outcomes to be independent of nutri-
tional status,15 and malnutrition alone does not seem to ex-
plain the results observed in this study. One explanation that
relates to BMI is that of frailty and functional status. Frailty,
as proposed by Fried and associates,26 includes such func-
tional measures as unintentional weight loss of more than
10 pounds, low physical activity, and grip strength.or less, 25 to 35, and 36 or more. P<.001. BMI, Body mass index.
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TABLE 6. Significant preoperative predictors of long-term survival
from multivariable survival analysis
Preoperative variables
Hazard ratio
(95% CI) P value
Age 1.04 (1.03–1.04) <.00001
Chronic lung disease 1.50 (1.30–1.72) <.00001
CVA 1.56 (1.32–1.85) <.00001
EF 0.99 (0.99–1.00) .04
Infectious endocarditis 1.58 (1.28–1.95) .00002
Female gender 1.27 (1.12–1.43) .0002
Heart failure 1.393 (1.22–1.58) <.00001
Renal failure 2.17 (1.80–2.61) <.00001
Renal failure requiring dialysis 2.69 (2.07–3.50) <.00001
CAD requiring CABG 1.29 (1.13–1.47) .0001
BMI 0.91 (0.86–0.97) .002
CVA, Cerebrovascular accident; EF, ejection fraction; CAD, coronary artery disease;
CABG, coronary artery bypass grafting; BMI, body mass index.
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DPerformance status is currently unaccounted for by the 3
major metrics used to predict mortality from cardiac surgery
(STS, Parsonnet, euroSCORE). The inclusion of perfor-
mance status or frailty scores in addition to BMI may im-
prove the accuracy of these mortality predictions. Also, as
newer technologies become available that obviate the need
for cardiopulmonary bypass (eg, percutaneous and transap-
ical valve technologies), patients with low BMI may benefit
from avoidance of bypass and the attendant inflammatory
response. Finally, in those patients for whom valve surgery
is elective, a nutritional and physical enhancement program
under the direction of trained professionals may serve to re-
duce morbidity and mortality.
Limitations
This study is limited by its observational nature and the
inherent limitations of a retrospective database study. Al-
though we controlled for confounding variables using logis-
tic regression analysis, it is likely that all factors influencing
selection bias were not accounted for in this analysis. Fur-
thermore, the heterogeneity of the study population may
make it difficult to draw broad conclusions on the basis of
these data. The current database did not have certain preop-
erative laboratory values (eg, albumin or prealbumin) that
may provide a more definitive objective assessment of mal-
nutrition. Finally, important operative variables were not
available, such as echocardiographic parameters, patient
prosthesis mismatch, or small prostheses, which have been
shown to affect long-term survival in certain subgroups.
CONCLUSIONS
Patients with low BMI experienced greater in-hospital
and long-term mortality when compared with other BMI
groups in this single-center study. Outcomes were indepen-
dent of valve procedure and concurrent CABG. These pa-
tients warrant careful risk stratification and may require1060 The Journal of Thoracic and Cardiovascular Surmore intensive preoperative testing. When possible, preop-
erative conditioning and nutrition enhancement may im-
prove short- and long-term outcomes. Further studies
dissecting the causal relationship of low BMI and poor
outcomes in patients undergoing cardiac valve surgery are
warranted.
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